Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors

The purpose of this clinical trial is to evaluate the safety and tolerability of SXRN Plasmid DNA Technique in patients with advanced solid tumors.

Participants needed: 28
Trial details
Phase: Early Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Jiangsu Nutai Biologics Co., LtdUpdated: May 15, 2026Locations: 1
Eligibility criteria

male or female, aged 18~75 at the time of signing the ICF; [+10]

has received any of the anti-tumor treatments below:a) received cytotoxic chemot... [+37]

Read more
Status: Recruiting

A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of SXRN Injection in Patients With Cancer Cachexia

This is a clinical study evaluating the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of SXRN Injection in cancer patients with anorexia-cachexia. Phase Ia employs a single-arm, open-label, dose-escalation design. Phase Ib, an extension of the study, utilizes a design of combination therapy with standard anti-tumor therapy for cancers including but not limited to pancreatic cancer, non-small cell lung cancer (NSCLC), and colon cancer.

Participants needed: 54
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Jiangsu Nutai Biologics Co., LtdUpdated: Dec 8, 2025Locations: 1
Eligibility criteria

1. Male or female, aged 18 to 75 years (inclusive) at the time of signing the in... [+11]

1. Reversible causes of reduced food intake as determined by the investigator, w... [+23]

Read more